PMC:7712180 / 25353-25535
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 886 | 52-61 | Chemical | denotes | zanamivir | MESH:D053243 |
| 887 | 63-74 | Chemical | denotes | oseltamivir | MESH:D053139 |
| 888 | 76-87 | Chemical | denotes | laninamivir | MESH:C546918 |
| 889 | 92-101 | Chemical | denotes | peramivir | MESH:C414210 |
| 894 | 133-142 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T151 | 0-182 | Sentence | denotes | Clinically approved NA inhibitors (NAIs), including zanamivir, oseltamivir, laninamivir and peramivir, are now used for treatment of infection with not only IAVs but also IBVs [171]. |